Home example 2 - Pharmamarketeer

farma-industrie

Roche’s Hemlibra stakes claim to be haemophilia market leader

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements its prospects in the field.

Pharmafile

3 x gelezen

farma-industrie

J&J stock tumbles after Reuters reports it hid asbestos in talc

After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its powder contained cancer-causing...

FiercePharma

3 x gelezen

overig

‘Europese regels nodig over transparantie banden zorg en farma’

Het openbaar maken van financiële banden tussen zorgverleners en de farmaceutische industrie in Europa kan beter. Ook in Nederland is er nog onvoldoende transparantie, concluderen onderzoekers van universiteiten in...

Skipr

3 x gelezen

onderzoek

Roche pulls plug on Alzheimer’s drug after Phase 3 failure

Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab in the treatment of early sporadic Alzheimer’s disease (AD), after it became...

InPharm.com

3 x gelezen

marketing

[column] Geïntegreerd merkdenken: van communicatie naar customer experience

Het laatste hoofdstuk van merkkroniek Brandr stond nog open voor extrapolatie naar het nu. Dit hiaat is nu opgevuld door hedendaagse merkdenkers. MarketingTribune presenteert deze reeks met als (voorlopige) slot-auteur:...

MarketingTribune

3 x gelezen

wet- en regelgeving

Soliris Gets Priority Review for Rare, Complement-Mediated CNS Disorder

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Soliris (eculizumab; Alexion) for use in patients with neuromyelitis optica spectrum...

Monthly Prescribing Reference (MPR): Drugs in the Pipeline

3 x gelezen

overig

EU-parlement stemt voor EMA in Amsterdam

De komst van het Europees Geneesmiddelenbureau (EMA) kan Nederland nagenoeg zeker niet meer ontglippen. Het Europees Parlement heeft de verhuizing van Londen naar Amsterdam goedgekeurd, op voorwaarde dat de autoriteiten...

Skipr

3 x gelezen

onderzoek

Study reveals mechanism involved in the development of diabetes, fatty liver

A research group including Professor OGAWA Wataru (Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine) and Project Associate Professor HOSOOKA Tetsuya (Division of Development of...

News-Medical.Net

3 x gelezen

technologie

New roles for clinicians in the age of artificial intelligence

Artificial intelligence New Roles for Clinicians in the Age of Artificial Intelligencehttps://doi.org/10.15212/bioi-2020-0014 Announcing a new article publication for BIO Integration journal. In this opinion article the...

EurekAlert

3 x gelezen

onderzoek

Time to Results Faster With Point-of-Care COVID-19 Testing

COVID-19 testing THURSDAY, Oct. 15, 2020 — Point-of-care testing is associated with large reductions in the time to results for patients presenting with suspected COVID-19, according to a study published online...

Drugs.com: Drug Information Online

3 x gelezen

Latest articles

Roche’s Hemlibra stakes claim to be haemophilia market leader

J&J stock tumbles after Reuters reports it hid asbestos in talc

‘Europese regels nodig over transparantie banden zorg en farma’

Roche pulls plug on Alzheimer’s drug after Phase 3 failure

[column] Geïntegreerd merkdenken: van communicatie naar customer experience

Soliris Gets Priority Review for Rare, Complement-Mediated CNS Disorder

EU-parlement stemt voor EMA in Amsterdam

Study reveals mechanism involved in the development of diabetes, fatty liver

New roles for clinicians in the age of artificial intelligence

Time to Results Faster With Point-of-Care COVID-19 Testing

Wekelijkse highlights per e-mail

Algemene informatie